Phathom Pharmaceuticals, Inc. PHAT Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s restricted cash?
- Phathom Pharmaceuticals, Inc. (PHAT) reported restricted cash of $2.86M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s restricted cash changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s restricted cash decreased by 0.0% year-over-year, from $2.86M to $2.86M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s restricted cash?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s restricted cash has grown at a 105.6% compound annual growth rate (CAGR), from $160K to $2.86M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.